Morgan Stanley Lowers Its Investment Rating on Inktomi
Morgan Stanley lowered its investment rating on Inktomi (INKT ) to neutral from outperform with Analyst Christopher Stix saying revenues for the Internet infrastructure software company could miss Wall Street's bar. The stock was off 4-3/4 at 13-3/4.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.